Breakthrough in cancer therapy targets key protein interaction to suppress tumors
 

Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS, and a key pathway for tumor growth.

More...